Clinical Trial Update: A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Zasocitinib in adults with psoriatic arthritis who have not previously used biologic medicines; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Zasocitinib (Zasocitinib)

Snippet

Sponsor: Takeda | Conditions: Psoriatic Arthritis | Phase 3 | Status: RECRUITING